Therefore, we believe that TEM, previously known as a targeted anti-cancer drug, can be developed as a new anti-cancer therapy that can effectively enhance cancer treatment by suppressing sEV PD-L1 secretion to improve the immune system in the body. This evidence concerns the gene CD274 and cancer.